Nitrogen and oxygen molecules in meningitis-associated labyrinthitis and hearing impairment

Infection

Volumn 36, Issue 1, 2008, Pages 2-14

  Klein, M ^a   Koedel, U ^a   Kastenbauer, S ^a   Pfister, H W ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIBIOTIC AGENT; ANTIOXIDANT; CEFTRIAXONE; CORTICOSTEROID; DEXAMETHASONE; MANGANESE TETRAKIS(4 BENZOIC ACID) PORPHYRIN; NITROGEN; OXYGEN; PEROXYNITRITE; PORPHYRIN DERIVATIVE;

ADJUVANT THERAPY; BACTERIAL MENINGITIS; BRAIN DAMAGE; CELL DAMAGE; CLINICAL TRIAL; COCHLEA; COMORBIDITY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MODEL; HAIR CELL; HEARING IMPAIRMENT; HUMAN; IMMUNE RESPONSE; INFECTION; INNATE IMMUNITY; INNER EAR DISEASE; LABYRINTHITIS; MOLECULE; NERVE INJURY; NONHUMAN; OSSIFICATION; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SPIRAL GANGLION; SUBARACHNOID SPACE; TEMPORAL BONE;

ANIMALS; ANTIOXIDANTS; COCHLEA; FREE RADICAL SCAVENGERS; HEARING LOSS; HUMANS; IMMUNITY, NATURAL; LABYRINTHITIS; MENINGITIS, BACTERIAL; NITRIC OXIDE SYNTHASE TYPE II; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; TOLL-LIKE RECEPTORS;

EID: 43049155992     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-007-7153-1     Document Type: Review

References (106)

1. World Health Organization: Epidemic meningococcal disease. WHO fact sheet No. 105 1998.
2. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, Lefkowitz L, Perkins BA: Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 1997; 337: 970-976.
3. Koedel U, Scheld WM, Pfister HW: Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis 2002; 2: 721-736.
4. Klein M, Koedel U, Pfister HW: Oxidative stress in pneumococcal meningitis: a future target for adjunctive therapy? Prog Neurobiol 2006; 80: 269-280.
5. Kastenbauer S, Pfister HW: Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain 2003; 126: 1015-1025.
6. Dodge PR, Davis H, Feigin RD, Holmes SJ, Kaplan SL, Jubelirer DP, Stechenberg BW, Hirsh SK: Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N Engl J Med 1984; 311: 869-874.
7. McIntyre P, Jepson R, Leeder S, Irwig L: The outcome of childhood Haemophilus influenzae meningitis. A population based study. Med J Aust 1993; 159: 766-772.
8. Roizen NJ: Etiology of hearing loss in children. Nongenetic causes. Pediatr Clin North Am 1999; 46: 49-64 x.
9. Billings KR, Kenna MA: Causes of pediatric sensorineural hearing loss: yesterday and today. Arch Otolaryngol Head Neck Surg 1999; 125: 517-521.
10. Lieu JE: Speech-language and educational consequences of unilateral hearing loss in children. Arch Otolaryngol Head Neck Surg 2004; 130: 524-530.
11. Rasmussen N, Johnsen NJ, Bohr VA: Otologic sequelae after pneumococcal meningitis: a survey of 164 consecutive cases with a follow-up of 94 survivors. Laryngoscope 1991; 101: 876-882.
12. Kaplan SL, Catlin FI, Weaver T, Feigin RD: Onset of hearing loss in children with bacterial meningitis. Pediatrics 1984; 73: 575-578.
13. Richardson MP, Reid A, Tarlow MJ, Rudd PT: Hearing loss during bacterial meningitis. Arch Dis Child 1997; 76: 134-138.
14. Vienny H, Despland PA, Lutschg J, Deonna T, Dutoit-Marco ML, Gander C: Early diagnosis and evolution of deafness in childhood bacterial meningitis: a study using brainstem auditory evoked potentials. Pediatrics 1984; 73: 579-586.
15. Bhatt S, Halpin C, Hsu W, Thedinger BA, Levine RA, Tuomanen E, Nadol JB: Hearing loss and pneumococcal meningitis: an animal model. Laryngoscope 1991; 101: 1285-1292.
16. Amaee FR, Comis SD, Osborne MP: NG-methyl-L-arginine protects the guinea pig cochlea from the cytotoxic effects of pneumolysin. Acta Otolaryngol 1995; 115: 386-391.
17. Osborne MP, Comis SD, Tarlow MJ, Stephen J: The cochlear lesion in experimental bacterial meningitis of the rabbit. Int J Exp Pathol 1995; 76: 317-330.
18. Winter AJ, Marwick S, Osborne M, Comis S, Stephen J, Tarlow M: Ultrastructural damage to the organ of corti during acute experimental Escherichia coli and pneumococcal meningitis in guinea pigs. Acta Otolaryngol 1996; 116: 401-407.
19. Kesser BW, Hashisaki GT, Spindel JH, Ruth RA, Scheld WM: Time course of hearing loss in an animal model of pneumococcal meningitis. Otolaryngol Head Neck Surg 1999; 120: 628-637.
20. Klein M, Koedel U, Pfister HW, Kastenbauer S: Morphological correlates of acute and permanent hearing loss during experimental pneumococcal meningitis. Brain Pathol 2003; 13: 1-10.
21. Brookhouser PE, Auslander MC, Meskan ME: The pattern and stability of postmeningitic hearing loss in children. Laryngoscope 1988; 98: 940-948.
22. Jiang ZD: Outcome of brain stem auditory electrophysiology in children who survive purulent meningitis. Ann Otol Rhinol Laryngol 1999; 108: 429-434.
23. Druss JG: Labyrinthitis secondary to meningococcic meningitis: a clinical and histopathologic study. Arch Otolaryngol 1936; 24: 19-28.
24. Igarashi M, Schuknecht H: Pneumococcal otitis media, meningitis, and labyrinthitis. Arch Otolaryngol 1962; 76: 126-130.
25. Paparella MM, Sugiura S: The pathology of suppurative labyrinthitis. Ann Otol Rhinol Laryngol 1967; 76: 554-586.
26. Schuknecht H, Montandon P: Pathology of the Ear in Pneumococcal Meningitis. Arch klin exp Ohr -, Nas - u Kehlk Heilk 1970; 195: 207-225.
27. Merchant SN, Gopen Q: A human temporal bone study of acute bacterial meningogenic labyrinthitis. Am J Otol 1996; 17: 375-385.
28. Moxon ER, Smith AL, Averill DR, Smith DH: Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis 1974; 129: 154-162.
29. Wiedermann BL, Hawkins EP, Johnson GS, Lamberth LB, Mason EO, Kaplan SL: Pathogenesis of labyrinthitis associated with Haemophilus influenzae type b meningitis in infant rats. J Infect Dis 1986; 153: 27-32.
30. Kaplan SL, Hawkins EP, Kline MW, Patrick GS, Mason EO Jr: Invasion of the inner ear by Haemophilus influenzae type b in experimental meningitis. J Infect Dis 1989; 159: 923-930.
31. Bhatt SM, Lauretano A, Cabellos C, Halpin C, Levine RA, Xu WZ, Nadol JB, Tuomanen E: Progression of hearing loss in experimental pneumococcal meningitis: correlation with cerebrospinal fluid cytochemistry. J Infect Dis 1993; 167: 675-683.
32. Rappaport JM, Bhatt SM, Kimura RS, Lauretano AM, Levine RA: Electron microscopic temporal bone histopathology in experimental pneumococcal meningitis. Ann Otol Rhinol Laryngol 1999; 108: 537-547.
33. Stoelinga GB, van Munster PJ: The behaviour of Evans blue (azodye T-1824) in the body after intravenous injection. Acta Physiol Pharmacol Neerl 1967; 14: 391-409.
34. Wolman M, Klatzo I, Chui E, Wilmes F, Nishimoto K, Fujiwara K, Spatz M: Evaluation of the dye-protein tracers in pathophysiology of the blood-brain barrier. Acta Neuropathol (Berl) 1981; 54: 55-61.
35. Kastenbauer S, Klein M, Koedel U, Pfister HW: Author Reply. Ann Neurol 2004; 55: 598.
36. Kastenbauer S, Klein M, Koedel U, Pfister HW: Reactive nitrogen species contribute to blood-labyrinth barrier disruption in suppurative labyrinthitis complicating experimental pneumococcal meningitis in the rat. Brain Res 2001; 904: 208-217.
37. Kimura RS, Nye CL, Southard RE: Normal and pathologic features of the limbus spiralis and its functional significance. Am J Otolaryngol 1990; 11: 99-111.
38. Jahnke K: The blood-perilymph barrier. Arch Otorhinolaryngol 1980; 228: 29-34.
39. Kikuchi T, Kimura RS, Paul DL, Takasaka T, Adams JC: Gap junction systems in the mammalian cochlea. Brain Res Brain Res Rev 2000; 32: 163-166.
40. Wu R, Hoshino T: Changes in off-lesion endocochlear potential following localized lesion in the lateral wall. Acta Otolaryngol 1999; 119: 550-554.
41. Feghali JG, Lefebvre PP, Staecker H, Kopke R, Frenz DA, Malgrange B, Liu W, Moonen G, Ruben RJ, Van de Water TR: Mammalian auditory hair cell regeneration/repair and protection: a review and future directions. Ear Nose Throat J 1998; 77: 276-285.
42. Shi X, Nuttall AL: Upregulated iNOS and oxidative damage to the cochlear stria vascularis due to noise stress. Brain Res 2003; 967: 1-10.
43. Sattler R, Tymianski M: Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol Neurobiol 2001; 24: 107-129.
44. Puel JL, Ruel J, Guitton M, Wang J, Pujol R: The inner hair cell synaptic complex: physiology, pharmacology and new therapeutic strategies. Audiol Neurootol 2002; 7: 49-54.
45. Pujol R, Puel JL: Excitotoxicity, synaptic repair, and functional recovery in the mammalian cochlea: a review of recent findings. Ann N Y Acad Sci 1999; 884: 249-254.
46. Sunami K, Yamane H, Nakagawa T, Takayama M, Konishi K: Glutamate toxicity induced degeneration of outer hair cells with a temporal increase of nitric oxide production in the guinea pig cochlea. Eur Arch Otorhinolaryngol 1999; 256: 323-329.
47. Nadol JB Jr, Hsu WC: Histopathologic correlation of spiral ganglion cell count and new bone formation in the cochlea following meningogenic labyrinthitis and deafness. Ann Otol Rhinol Laryngol 1991; 100: 712-716.
48. Raphael Y, Altschuler RA: Structure and innervation of the cochlea. Brain Res Bull 2003; 60: 397-422.
49. Li L, Shui QX, Li X: Neuroprotective effects of brain-derived neurotrophic factor (BDNF) on hearing in experimental pneumococcal meningitis. J Child Neurol 2005; 20: 51-56.
50. Eisenberg LS, Luxford WM, Becker TS, House WF: Electrical stimulation of the auditory system in children deafened by meningitis. Otolaryngol Head Neck Surg 1984; 92: 700-705.
51. al Shaikh AH, Metwalli AA: Experience with cochlear implants in postmeningitic cases. Adv Otorhinolaryngol 2000; 57: 240-242.
52. Rauch SD: Vestibular histopathology of the human temporal bone. What can we learn? Ann N Y Acad Sci 2001; 942: 25-33.
53. Tinling SP, Colton J, Brodie HA: Location and timing of initial osteoid deposition in postmeningitic labyrinthitis ossificans determined by multiple fluorescent labels. Laryngoscope 2004; 114: 675-680.
54. Nabili V, Brodie HA, Neverov NI, Tinling SP: Chronology of labyrinthitis ossificans induced by Streptococcus pneumoniae meningitis. Laryngoscope 1999; 109: 931-935.
55. Rauch SD, Herrmann BS, Davis LA, Nadol JB Jr: Nucleus 22 cochlear implantation results in postmeningitic deafness. Laryngoscope 1997; 107: 1606-1609.
56. Incesulu A, Nadol JB Jr: Correlation of acoustic threshold measures and spiral ganglion cell survival in severe to profound sensorineural hearing loss: implications for cochlear implantation. Ann Otol Rhinol Laryngol 1998; 107: 906-911.
57. Dichgans M, Jager L, Mayer T, Schorn K, Pfister HW: Bacterial meningitis in adults: demonstration of inner ear involvement using high-resolution MRI. Neurology 1999; 52: 1003-1009.
58. Firbas W, Gruber H, Wicke W: The blood vessels of the limbus spiralis. Arch Otorhinolaryngol 1981; 232: 131-137.
59. Takahashi T, Kimura RS: The ultrastructure of the spiral ligament in the Rhesus monkey. Acta Otolaryngol 1970; 69: 46-60.
60. Gopen Q, Rosowski JJ, Merchant SN: Anatomy of the normal human cochlear aqueduct with functional implications. Hear Res 1997; 107: 9-22.
61. Harris JP, Ryan AF: Fundamental immune mechanisms of the brain and inner ear. Otolaryngol Head Neck Surg 1995; 112: 639-653.
62. Schroder NW, Morath S, Alexander C, Hamann L, Hartung T, Zahringer U, Gobel UB, Weber JR, Schumann RR: Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 2003; 278: 15587-15594.
63. Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1: 135-145.
64. Opitz B, Puschel A, Schmeck B, Hocke AC, Rosseau S, Hammerschmidt S, Schumann RR, Suttorp N, Hippenstiel S: Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J Biol Chem 2004; 279: 36426-36432.
65. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D: Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999; 163: 1-5.
66. Jedrzejas MJ: Pneumococcal virulence factors: structure and function. Microbiol Mol Biol Rev 2001; 65: 187-207.
67. Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, Kurt-Jones E, Paton JC, Wessels MR, Golenbock DT: Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci USA 2003; 100: 1966-1971.
68. Comis SD, Osborne MP, Stephen J, Tarlow MJ, Hayward TL, Mitchell TJ, Andrew PW, Boulnois GJ: Cytotoxic effects on hair cells of guinea pig cochlea produced by pneumolysin, the thiol activated toxin of Streptococcus pneumoniae. Acta Otolaryngol 1993; 113: 152-159.
69. Winter AJ, Comis SD, Osborne MP, Tarlow MJ, Stephen J, Andrew PW, Hill J, Mitchell TJ: A role for pneumolysin but not neuraminidase in the hearing loss and cochlear damage induced by experimental pneumococcal meningitis in guinea pigs. Infect Immun 1997; 65: 4411-4418.
70. Friedland IR, Paris MM, Hickey S, Shelton S, Olsen K, Paton JC, McCracken GH: The limited role of pneumolysin in the pathogenesis of pneumococcal meningitis. J Infect Dis 1995; 172: 805-809.
71. Klein M, Schmidt C, Kastenbauer S, Kirschning CJ, Wagner H, Paul R, Popp B, Pfister HW, Koedel U: MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis. J Infect Dis 2007 (in press).
72. Jung TT, Llaurado RJ, Nam BH, Park SK, Kim PD, John EO: Effects of nitric oxide on morphology of isolated cochlear outer hair cells: possible involvement in sensorineural hearing loss. Otol Neurotol 2003; 24: 682-685.
73. Hess A, Bloch W, Huverstuhl J, Su J, Stennert E, Addicks K, Michel O: Expression of inducible nitric oxide synthase (iNOS/NOS II) in the cochlea of guinea pigs after intratympanical endotoxin-treatment. Brain Res 1999; 830: 113-122.
74. Watanabe K, Hess A, Zumeger C, Stennert E, Bloch W, Addicks K, Michel O: Changes of the compound action potential (CAP) and the expression of inducible nitric oxide synthase (iNOS/NOS II) in the cochlea under the inflammatory condition (1). Hear Res 2000; 145: 149-155.
75. Brandt CT, Caye-Thomasen P, Lund SP, Worsoe L, Ostergaard C, Frimodt-Moller N, Espersen F, Thomsen J, Lundgren JD: Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes. Neurobiol Dis 2006; 23: 300-311.
76. Guzik TJ, Korbut R, Adamek-Guzik T: Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 2003; 54: 469-487.
77. Liaudet L, Soriano FG, Szabo C: Biology of nitric oxide signaling. Crit Care Med 2000; 28: N37-N52.
78. Amaee FR, Comis SD, Osborne MP, Drew S, Tarlow MJ: Possible involvement of nitric oxide in the sensorineural hearing loss of bacterial meningitis. Acta Otolaryngol 1997; 117: 329-336.
79. Pai N, Zdanski CJ, Gregory CW, Prazma J, Carrasco V: Sodium nitroprusside/nitric oxide causes apoptosis in spiral ganglion cells. Otolaryngol Head Neck Surg 1998; 119: 323-330.
80. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271: C1424-C1437.
81. Koedel U, Pfister HW: Oxidative stress in bacterial meningitis. Brain Pathol 1999; 9: 57-67.
82. Kastenbauer S, Koedel U, Pfister HW: Oxidative brain damage by peroxynitrite in bacterial meningitis: a target for adjunctive therapy? Curr Med Chem 2002; 2: 109-127.
83. Klein M, Koedel U, Pfister HW, Kastenbauer S: Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy. Ann Neurol 2003; 54: 451-458.
84. Ge NN, Brodie SA, Tinling SP, Brodie HA: The effects of superoxide dismutase in gerbils with bacterial meningitis. Otolaryngol Head Neck Surg 2004; 131: 563-572.
85. Szabo C: The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 1996; 6: 79-88.
86. Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanaraman B, Barnes S, Kirk M, Freeman BA: Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 1994; 269: 26066-26075.
87. Kieseier BC, Paul R, Koedel U, Seifert T, Clements JM, Gearing AJ, Pfister HW, Hartung HP: Differential expression of matrix metalloproteinases in bacterial meningitis. Brain 1999; 122: 1579-1587.
88. Paul R, Lorenzl S, Koedel U, Sporer B, Vogel U, Frosch M, Pfister HW: Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol 1998; 44: 592-600.
89. Arditi M, Mason EO Jr, Bradley JS, Tan TQ, Barson WJ, Schutze GE, Wald ER, Givner LB, Kim KS, Yogev R, Kaplan SL: Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998; 102: 1087-1097.
90. Lebel MH, Freij BJ, Syrogiannopoulos GA, Chrane DF, Hoyt MJ, Stewart SM, Kennard BD, Olsen KD, McCracken GH Jr: Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N Engl J Med 1988; 319: 964-971.
91. McIntyre PB, Berkey CS, King SM, Schaad UB, Kilpi T, Kanra GY, Perez CM: Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 1997; 278: 925-931.
92. Bhatt SM, Cabellos C, Nadol JB Jr, Halpin C, Lauretano A, Xu WZ, Tuomanen E: The impact of dexamethasone on hearing loss in experimental pneumococcal meningitis. Pediatr Infect Dis J 1995; 14: 93-96.
93. Rappaport JM, Bhatt SM, Burkard RF, Merchant SN, Nadol JB: Prevention of hearing loss in experimental pneumococcal meningitis by administration of dexamethasone and ketorolac. J Infect Dis 1999; 179: 264-268.
94. Thomas R, Le Tulzo Y, Bouget J, Camus C, Michelet C, Le Corre P, Bellissant E: Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group. Intensive Care Med 1999; 25: 475-480.
95. Gijwani D, Kumhar MR, Singh VB, Chadda VS, Soni PK, Nayak KC, Gupta BK: Dexamethasone therapy for bacterial meningitis in adults: a double blind placebo control study. Neurol India 2002; 50: 63-67.
96. de Gans J, van de Beek D: Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347: 1549-1556.
97. van de BD, de GJ, McIntyre P, Prasad K: Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2007; CD004405.
98. Smilkstein MJ, Bronstein AC, Linden C, Augenstein WL, Kulig KW, Rumack BH: Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med 1991; 20: 1058-1063.
99. Kelly GS: Clinical applications of N-acetylcysteine. Altern Med Rev 1998; 3: 114-127.
100. Bailey B, McGuigan MA: Management of anaphylactoid reactions to intravenous N-acetylcysteine. Ann Emerg Med 1998; 31: 710-715.
101. Rodriguez AF, Kaplan SL, Hawkins EP, Mason EO: Hematogenous pneumococcal meningitis in the infant rat: description of a model. J Infect Dis 1991; 164: 1207-1209.
102. Blank AL, Davis GL, VanDeWater TR, Ruben RJ: Acute Streptococcus pneumoniae meningogenic labyrinthitis. An experimental guinea pig model and literature review. Arch Otolaryngol Head Neck Surg 1994; 120: 1342-1346.
103. Winter AJ, Comis SD, Osborne MP, Hayward TL, Stephen J, Tarlow MJ: Ototoxicity resulting from intracochlear perfusion of Streptococcus pneumoniae in the guinea pig is modified by cefotaxime or amoxycillin pretreatment. J Infect 1998; 36: 73-77.
104. Skinner LJ, Beurg M, Mitchell TJ, Darrouzet V, Aran JM, Dulon D: Intracochlear perfusion of pneumolysin, a pneumococcal protein, rapidly abolishes auditory potentials in the guinea pig cochlea. Acta Otolaryngol 2004; 124: 1000-1007.
105. Li L, Shui QX, Li X: Neuroprotective effects of brain-derived neurotrophic factor (BDNF) on hearing in experimental pneumococcal meningitis. J Child Neurol 2005; 20: 51-56.
106. Meli DN, Coimbra RS, Erhart DG, Loquet G, Bellac CL, Tauber MG, Neumann U, Leib SL: Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis. Infect Immun 2006; 74: 3890-3896.